Table 4.
Medication at discharge and 12 months according to gender
| |
At discharge |
At 12 months* |
||||
|---|---|---|---|---|---|---|
|
Women |
Men |
p value |
Women |
Men |
p value | |
| (n = 253) | (n = 795) | (n = 97) | (n = 375) | |||
| ASS |
91% |
94% |
0.05 |
56% |
65% |
0.07 |
| Clopidogrel |
88% |
93% |
0.02 |
31% |
40% |
0.10 |
| Anticoagulation |
10% |
9% |
0.80 |
8% |
5% |
0.20. |
| Triple therapy |
8% |
8% |
0.69 |
0% |
2% |
0.20. |
| Beta-Blocker |
84% |
90% |
<0.01 |
51% |
61% |
0.06 |
| ACE inhibitor |
76% |
79% |
0.18 |
50% |
58% |
0.15 |
| Lipid lowering drug | 71% | 84% | <0.01 | 53% | 61% | 0.14 |
Data presented as percentage of patients.
*12-month data only available for network B.